Alinity s System REF 06P16-01. An automated immunoassay analyzer for In Vitro diagnostic use in blood donor screening, plasma and plasmapheresis screening, and organ donor centers, hospitals, and reference laboratories.
Published August 18, 2021 · Recall initiated: July 12, 2021
Summary
FDA records medical device Class II recall Z-2276-2021, published August 18, 2021 and initiated July 12, 2021. Recalling firm: Abbott Laboratories, Inc; Status: Ongoing; Reported quantity: 260 systems; Lot: Model Number: LN 06P16-01 Serial numbers AS1001 through AS1330. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
A design defect (hardware and software) allows liquid waste pressure to build up and potentially spray users/operators.
What to do
Voluntary: Firm initiated · Visit
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Abbott Laboratories, Inc
- Distributor
- Worldwide distribution. US nationwide, Australia, Bahrain, Belgium, Brazil, China, Colombia, Croatia, Egypt, Germany, Greece, Hong Kong, Hungary, Iran, Ireland, Israel, Italy, Jordan, Kuwait, Mexico, Netherlands, Pakistan, Poland, Portugal, Saudi Arabia, Serbia, Slovenia, South Africa, Spain, Tanzania, United Arab Emirates, United Kingdom, Ukraine and Zimbabwe.
- Lot
- Model Number: LN 06P16-01 Serial numbers AS1001 through AS1330
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDACombipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.14 mg per day, 50/140 Twice Weekly, RxAugust 25, 2021
- FDAGrasper/Retriever, Alligator Jaw, Rat Tooth 2.4 mm x 8 mm x 230 cm Catalog Number: 7226 Intended use: singleAugust 18, 2021
- FDAARCHITECT C System Mixer - Product Usage: The ARCHITECT Clinical Chemistry System is designed to performApril 15, 2020
- FDAC4 is an in vitro diagnostic assay for the quantitative determination of C4 in human serum or plasma. AntigenJuly 31, 2019
- FDAARCHITECT c4000 part number 02P24; ARCHITECT c8000 part number 01G06; ARCHITECT c16000 part number 03L77November 29, 2017
- FDAARCHITECT c4000 Cuvette Segment, List number 02P75-01. The firm name on the label is Abbott Laboratories,October 18, 2017
Questions about this recall
Was Alinity s System REF 06P16-01. An automated immunoassay analyzer for In Vitro diagnostic use in blood donor screening, plasma and plasmapheresis screening, and organ donor centers, hospitals, and reference laboratories. recalled?
Yes. FDA published recall Z-2276-2021 on August 18, 2021. Reported hazard: A design defect (hardware and software) allows liquid waste pressure to build up and potentially spray users/operators.
What should I do if I have this product?
Voluntary: Firm initiated · Visit